Suryaa Business Desk: Market experts are expressing significant concerns regarding the valuation expectations for the upcoming initial public offering (IPO) of the Swiss-Chinese agricultural giant, Syngenta. Breakingviews has raised concerns over the company's target valuation of between $66 billion and $88 billion for its proposed public issue on the Hong Kong Stock Exchange.
Market skepticism has emerged as Syngenta, primarily a manufacturer of pesticides and fertilizers, seeks a high valuation by positioning itself as an advanced biotechnology company. Reports indicate that the Sinochem-owned firm is seeking a multiple of 15 to 20 times its core earnings (EBITDA). Financial analysts suggest that this valuation is overly optimistic given the current negative trends in the agricultural market, the impact of climate change, and the global decline in farmers' purchasing power.
While the company is attempting to project a technology-driven business model, experts warn that investors are likely to evaluate it as a traditional agrochemical firm. Following a failed IPO attempt on the Shanghai Stock Exchange, the company is making efforts to secure funding through the Hong Kong market. Analysts suggest that if the company ignores market realities and insists on a high valuation, it may struggle to receive the expected response from investors. Observers note that as global investors prioritize fundamental metrics, there is a need for Syngenta to reconsider its valuation estimates.
